Stock Ratios
Making an investment decision in the stock market involves a certain amount of risk, so it's important to thoroughly review a company's stock before making any decisions. Stock float, number of short positions and outstanding shares are among the many factors an investor should take into account.
profit margin TTM
-151.15%
operating margin TTM
-165.91%
revenue TTM
41.50 Million
revenue per share TTM
0.38$
valuation ratios | |
|---|---|
| pe ratio | -9.57 |
| peg ratio | -0.31 |
| price to book ratio | 6.01 |
| price to sales ratio | 14.40 |
| enterprise value multiple | -9.44 |
| price fair value | 6.01 |
profitability ratios | |
|---|---|
| gross profit margin | 98.23% |
| operating profit margin | -165.91% |
| pretax profit margin | -150.99% |
| net profit margin | -151.15% |
| return on assets | -47.83% |
| return on equity | -60.8% |
| return on capital employed | -57.56% |
liquidity ratios | |
|---|---|
| current ratio | 8.88 |
| quick ratio | 8.88 |
| cash ratio | 3.16 |
efficiency ratios | |
|---|---|
| days of inventory outstanding | 0.00 |
| operating cycle | 0.00 |
| days of payables outstanding | 689.48 |
| cash conversion cycle | -689.48 |
| receivables turnover | 0.00 |
| payables turnover | 0.53 |
| inventory turnover | 0.00 |
debt and solvency ratios | |
|---|---|
| debt ratio | 0.17 |
| debt equity ratio | 0.22 |
| long term debt to capitalization | 0.00 |
| total debt to capitalization | 0.18 |
| interest coverage | 0.00 |
| cash flow to debt ratio | -4.19 |
cash flow ratios | |
|---|---|
| free cash flow per share | -1.32 |
| cash per share | 1.38 |
| operating cash flow per share | -1.31 |
| free cash flow operating cash flow ratio | 1.01 |
| cash flow coverage ratios | -4.19 |
| short term coverage ratios | 0.00 |
| capital expenditure coverage ratio | -153.49 |
Frequently Asked Questions
When was the last time Tango Therapeutics, Inc. (NASDAQ:TNGX) reported earnings?
Tango Therapeutics, Inc. (TNGX) published its most recent earnings results on 04-11-2025.
What is Tango Therapeutics, Inc.'s current ROE?
An investor's main concern is the profitability ratios of a company so that they are able to understand how it performs financially. Investors are interested in finding out how effectively a business is using their cash to produce earnings, which is why return on equity (ROE) ratio is important. Tango Therapeutics, Inc. (NASDAQ:TNGX)'s trailing twelve months ROE is -60.8%.
What are ROA telling us?
The Return on Assets (ROA) ratio measures how profitable a company is relative to its total assets. Tango Therapeutics, Inc. (TNGX) currently has a ROA of -47.83%. Companies that manage their assets effectively will have greater returns, while those that do so poorly would suffer lower returns.
Where did TNGX's net profit margin stand at?
TNGX reported a profit margin of -151.15% in the last quarter. A company's profit margin, also known as its revenue ratio or gross profit ratio, reflects the amount of revenue that an organization earns compared to its net income. In general, a higher ratio implies greater profit, and vice versa.
What is TNGX's short-term liquidity position?
Apple's current ratio, which measures its ability to pay short-term obligations, was 8.88 in the most recent quarter. The quick ratio stood at 8.88, with a Debt/Eq ratio of 0.22.